We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Howell-Jolly Body-Like Inclusions Correlated with Myelodysplastic Syndrome

By LabMedica International staff writers
Posted on 07 Jan 2019
Print article
Image: Howell-Jolly body–like inclusion within neutrophil (arrow). It appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophil. Photos were taken from different cases (Photo courtesy of University of Texas Health Science Center at Houston).
Image: Howell-Jolly body–like inclusion within neutrophil (arrow). It appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophil. Photos were taken from different cases (Photo courtesy of University of Texas Health Science Center at Houston).
Howell-Jolly body–like inclusions have been previously associated with patients who are human immunodeficiency virus (HIV) infected, taking antiviral medications, and immunosuppressed. These inclusions appear in neutrophils and resemble Howell-Jolly bodies of normoblasts in abnormal erythropoiesis.

Compared with a Barr body, which appears as a drumstick-shaped appendage of a nuclear lobe, a Howell-Jolly body-like inclusion appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophils. Howell-Jolly body-like inclusions are thought to represent a product of dysplastic granulopoiesis.

Scientists at the University of Texas Health Science Center at Houston (Houston, TX, USA) selected as a study group a total of 11 patients who underwent bone marrow biopsy and were newly diagnosed with myelodysplastic syndrome (MDS) that were treatment naïve, between 2010 and 2017. In addition, 20 treatment-naïve patients who underwent bone marrow biopsy but were diagnosed with no significant pathologic alteration in the institution were selected as the control group.

The peripheral blood and bone marrow aspirate smears were retrospectively studied. A minimum of 300 neutrophils and myeloid precursors from each bone marrow aspirate smear and 20 neutrophils from each peripheral blood smear were screened. Each patient's clinical information from the electronic medical record was reviewed to ensure none of them had a history of HIV or was taking immunosuppressants and/or antiviral medications.

The team reported eight of 11 cases (72%) in the study group showed detached intracytoplasmic inclusions in mature neutrophils consistent with Howell-Jolly body-like inclusions. Morphologically, these inclusions are densely basophilic and are “free-floating” within the neutrophilic cytoplasm. Among the eight inclusion-positive cases, Howell-Jolly body-like inclusions were identified in less than 5% of the neutrophil population. Furthermore, Howell-Jolly body-like inclusions were identified within less than 1% of the myeloid precursor population in one of the eight inclusion-positive cases. Of the 20 cases from the control group, no Howell-Jolly body-like inclusion was identified, which suggests that Howell-Jolly body-like inclusion is associated with MDS.

The authors concluded that Howell-Jolly body-like inclusions seem to correlate with immunosuppression and antiviral therapies with nucleoside analogs. They proposed that the formation of Howell-Jolly body-like inclusions is the consequence of dysplasia, and hence its correlation not only with the abovementioned conditions, but also with MDS. The inclusions are, however, seen in only a minority of white cells (<5%), which is probably why they were not brought to practicing pathologists' awareness in the past. The study was published in the January 2019 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
University of Texas Health Science Center at Houston

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.